Abstract
Graves’ disease (GD) is the most prevalent autoimmune disease in the United States with a peak incidence in the fifth to sixth decades of life and a female to male predominance of ∼10:1. In recipients of allogeneic bone marrow and peripheral blood stem cell transplants, GD recurs in previously affected recipients, occurs in unaffected recipients by adoptive transfer of autoimmune thyroiditis from an affected donor, and occurs less frequently in unaffected recipients transplanted with unaffected donors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
